Skip to search formSkip to main contentSkip to account menu

Gadoxetic acid

Known as: Dihydrogen (N((2s)-2-(bis(carboxymethyl)amino)-3-(p-ethoxyphenyl)propyl)-N-(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))gadolinate(2-) 
National Institutes of Health

Related topics

Related topics

3 relations
Gadoxetate Disodiumgadolinium ethoxybenzyl DTPA

Broader (1)

gadoxetate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Peritumoral decreased uptake area of gadoxetic acid enhanced magnetic resonance imaging and tumor recurrence after surgical resection in hepatocellular carcinoma
Abstract Recently, it has been suggested that peritumoral decreased uptake area (PDUA) in the hepatobiliary phase (HBP) of… 
2017
2017
Hepatoblastoma with solid and multicystic aspect mimicking a mesenchymal hamartoma: imaging and anatomopathologic findings
A 29-day-old infant was evaluated at our center for a hepatic mass found during gestation. Ultrasound revealed a heterogeneous… 
2016
2016
Prediction of postoperative liver failure using gadoxetic acid‐enhanced magnetic resonance imaging in patients with hepatocellular carcinoma
We intended to determine the usefulness of gadoxetic acid‐enhanced magnetic resonance (MR) imaging on preoperative prediction of… 
2014
2014
Three-Tesla magnetic resonance elastography for hepatic fibrosis: comparison with diffusion-weighted imaging and gadoxetic acid-enhanced magnetic resonance imaging.
AIM To evaluate the feasibility of 3-Tesla magnetic resonance elastography (MRE) for hepatic fibrosis and to compare that with… 
Review
2014
Review
2014
Value of diffusion-weighted MRI for differentiating malignant from benign intraductal papillary mucinous neoplasms of the pancreas.
OBJECTIVE The purpose of this study was to evaluate whether the use of diffusion-weighted MRI (DWI) increases diagnostic accuracy… 
2014
2014
Atypical Findings of Focal Nodular Hyperplasia with Gadoxetic Acid (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging
We report two cases of focal nodular hyperplasia in patients following gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance… 
2013
2013
Hypervascular hepatocellular carcinomas showing hyperintensity on hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging: a possible subtype with mature hepatocyte nature
PurposeWe evaluated molecular features of hypervascular hepatocellular carcinoma (HCC) that shows iso- or hyperintensity… 
2012
2012
Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist®)-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single…
PurposeTo compare the relative diagnostic performance of MDCT, PET/CT and Primovist-enhanced MRI (P-MRI) in the pre-resection… 
2011
2011
Evaluation of possible drug–drug interaction between gadoxetic acid and erythromycin as an inhibitor of organic anion transporting peptides (OATP)
To evaluate if erythromycin compromises liver‐specific enhancement of gadoxetic acid; both compounds competing in organic anion… 
2011
2011
Current limitations and potential breakthroughs for the early diagnosis of hepatocellular carcinoma.
Recently, Gadoxetic acid (Gd-EOB-DTPA; Primovist®; Bayer Schering Pharma), a tissue-specific contrast material, has been used for… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)